Boston Scientific Corp’s recent filing unveils that its Officer Carruthers Wendy acquired Company’s shares for reported $1.0 million on Feb 14 ’25. In the deal valued at $106.45 per share,9,393 shares were bought.
Then, JOHN B SORENSON bought 1,201 shares, generating $127,678 in total proceeds.
Before that, Sorenson John Bradley sold 6,389 shares. Boston Scientific Corp shares valued at $671,249 were divested by the EVP, Global Operations at a price of $105.06 per share. As a result of the transaction, Sorenson John Bradley now holds 24,293 shares, worth roughly $2.58 million.
Deutsche Bank upgraded its Boston Scientific Corp [BSX] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Needham’s analysts, who decreased its forecast for the stock in mid October from “a Buy” to “a Hold”. Goldman began covering BSX with “Buy” recommendation on May 30, 2024. Mizuho revised its rating on February 01, 2024. It rated BSX as “a Buy” which previously was an “a Neutral”.
Price Performance Review of BSX
On Friday, Boston Scientific Corp [NYSE:BSX] saw its stock fall -0.03% to $106.11. Over the last five days, the stock has gained 0.82%. Boston Scientific Corp shares have risen nearly 18.80% since the year began. Nevertheless, the stocks have risen 63.32% over the past one year. While a 52-week high of $107.17 was reached on 02/05/25, a 52-week low of $65.00 was recorded on 01/02/25. SMA at 50 days reached $96.16, while 200 days put it at $84.24.
Levels Of Support And Resistance For BSX Stock
The 24-hour chart illustrates a support level at 105.68, which if violated will result in even more drops to 105.25. On the upside, there is a resistance level at 106.63. A further resistance level may holdings at 107.14. The Relative Strength Index (RSI) on the 14-day chart is 80.09, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.55, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 16.38%. Stochastics %K at 82.39% indicates the stock is a selling.
How much short interest is there in Boston Scientific Corp?
A steep rise in short interest was recorded in Boston Scientific Corp stocks on 2025-01-31, dropping by -4.07 million shares to a total of 10.45 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-31 was 14.52 million shares. There was a decline of -38.98%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on July 19, 2023 when Robert W. Baird began covering the stock and recommended ‘”an Outperform”‘ rating along with a $59 price target.
